When the standard approach to acute toxoplasmosis is not suitable, a defined set of alternative regimens is available. This protocol outlines the clinical context and the evidence-based options for these situations.
This protocol applies to patients with acute toxoplasmosis (ICD-11 1F57.Z) for whom alternative antiparasitic treatment options are appropriate. The full protocol specifies the relevant clinical criteria.
Alternative regimens for this infection include fixed-combination antibiotic therapy and selected antiparasitic agents. The complete set of alternatives, selection guidance, and all clinical considerations are detailed in the full structured protocol.